2m 2m 2m 2m 2m 2m 2m
Vericel (VCEL)
NASDAQ
$40.16+$0.72 (+1.83%)
Price as of Oct 02, 2026 5:07 PM EDT- $2.0BMarket Cap
- 25.13%1-Year Change
- BiotechnologyIndustry
Vericel (VCEL)
$40.16+$0.72 (+1.83%)
VCEL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $39.44 | ||
Change | -$0.70 (-1.74%) | ||
Open | $40.27 | ||
High | $40.72 | ||
Low | $39.29 | ||
Previous Close | $40.14 | ||
Volume | 497,333 | ||
30-Day Average Volume | 503,032 | ||
1-Week Change | 0.36% | ||
1-Month Change | -2.62% | ||
1-Year Change | 25.13% | ||
3-Year Change | 17.66% | ||
5-Year Change | -21.62% | ||
Fundamentals | |||
Shares Outstanding | 51.2M | ||
Total Assets | $502.9M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $77.5M | ||
Net Income | $2.2M | ||
Free Cash Flow | $14.3M | ||
EBIT | $2.2M | ||
EBITDA | $5.8M | ||
Net Working Capital | $212.2M | ||
EPS | $0.04 | ||
Enterprise Value/EBITDA | 325 | ||
Enterprise Value/Revenue | 24 | ||
P/B | 5 | ||
P/E | 986 | ||
PEG | 7 | ||
Price/Free Cash Flow | 142 | ||
Price/Operating Cash Flow | 125 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/16/2013 | ||
Earnings & Revenue